Quick Answer
China SXT Pharmaceuticals, Inc. reported Total Revenue of $1.93 million for the year ending 2024.
- China SXT Pharmaceuticals, Inc. showed a decrease of -2.2% in Total Revenue from 2023 to 2024.
- This data is from China SXT Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on August 13, 2024.
- XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2017 to 2024), China SXT Pharmaceuticals, Inc.'s Total Revenue has declined by 60.5%.
- Historical annual values: Fiscal year 2024: $1.93 million | Fiscal year 2023: $1.97 million | Fiscal year 2022: $2.60 million | Fiscal year 2021: $4.78 million | Fiscal year 2020: $5.16 million | Fiscal year 2019: $7.01 million | Fiscal year 2018: $7.02 million | Fiscal year 2017: $4.88 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: